Q1 2015 13F Holders as of 31 Mar 2015
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
99,963,154
-
Total 13F shares
-
85,169,982
-
Share change
-
+9,817,842
-
Total reported value
-
$3,380,013,692
-
Put/Call ratio
-
74%
-
Price per share
-
$39.71
-
Number of holders
-
171
-
Value change
-
+$405,563,981
-
Number of buys
-
106
-
Number of sells
-
68
Institutional Holders of NEUROCRINE BIOSCIENCES INC - Common Stock, $0.001 par value (NBIX) as of Q1 2015
As of 31 Mar 2015,
NEUROCRINE BIOSCIENCES INC - Common Stock, $0.001 par value (NBIX) was held by
171 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
85,169,982 shares.
The largest 10 holders included
FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, ORBIMED ADVISORS LLC, VANGUARD GROUP INC, PERCEPTIVE ADVISORS LLC, BlackRock Fund Advisors, BB BIOTECH AG, Visium Asset Management, LP, PointState Capital LP, and WESTFIELD CAPITAL MANAGEMENT CO LP.
This page lists
171
institutional shareholders reporting positions in this security
for the Q1 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.